Clinical trial
Observational Study of Pergolide Mesylate and Cardiac Valvulopathy
NCT00311532 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00311532 |
|---|---|
| Title | Observational Study of Pergolide Mesylate and Cardiac Valvulopathy |
| Official title | Observational Study to Determine the Incidence of New-Onset Valvulopathy in Patients Treated With Pergolide as Second-Line Therapy for Parkinson's Disease |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Parkinson Disease |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Apr 6, 2006 |
| Last update posted | Jul 18, 2007 |
| Countries | Belgium, France, Germany, Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: